相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Non-clinical safety evaluation of repeated intramuscular administration of the AS15 immunostimulant combined with various antigens in rabbits and cynomolgus monkeys
N. Gacron et al.
JOURNAL OF APPLIED TOXICOLOGY (2016)
Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy
Christopher A. Klebanoff et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
Blocking Tumor Necrosis Factor a Enhances CD8 T-cell-Dependent Immunity in Experimental Melanoma
Florie Bertrand et al.
CANCER RESEARCH (2015)
CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function
Eunyoung Chun et al.
CELL REPORTS (2015)
Tumoral Immune Resistance Mediated by Enzymes That Degrade Tryptophan
Nicolas van Baren et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Molecular Pathways: Myeloid Complicity in Cancer
Ingunn M. Stromnes et al.
CLINICAL CANCER RESEARCH (2014)
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
Gregory T. Motz et al.
NATURE MEDICINE (2014)
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Pierre G. Coulie et al.
NATURE REVIEWS CANCER (2014)
Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer
Je-In Youn et al.
NATURE IMMUNOLOGY (2013)
Fas expression by tumor stroma is required for cancer eradication
Joanna J. Listopad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
Stefani Spranger et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Interferon-γ-induced PD-L1 surface expression on human oral squamous carcinoma via PKD2 signal pathway
Jiao Chen et al.
IMMUNOBIOLOGY (2012)
Minimal Tolerance to a Tumor Antigen Encoded by a Cancer-Germline Gene
Ivo J. Huijbers et al.
JOURNAL OF IMMUNOLOGY (2012)
Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice
Je-In Youn et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Epithelial-Mesenchymal-Transition-Like and TGFβ Pathways Associated with Autochthonous Inflammatory Melanoma Development in Mice
Maria Wehbe et al.
PLOS ONE (2012)
The pros and cons of chemokines in tumor immunology
Antonella Viola et al.
TRENDS IN IMMUNOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Tumor-Initiated Inflammation Overrides Protective Adaptive Immunity in an Induced Melanoma Model in Mice
Saidi M. Soudja et al.
CANCER RESEARCH (2010)
The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity
Je-In Youn et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Arginase I-Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytes
Paulo C. Rodriguez et al.
CANCER RESEARCH (2009)
Membrane-bound Fas ligand only is essential for Fas-induced apoptosis
Lorraine A. O' Reilly et al.
NATURE (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness
Gerald Willimsky et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Use of a fluorescently labeled poly-caspase inhibitor for in vivo detection of apoptosis related to vascular-targeting agent arsenic trioxide for cancer therapy
Robert J. Griffin et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2007)
Comparative prime-boost vaccinations using Semliki Forest virus, adenovirus, and ALVAC vectors demonstrate differences in the generation of a protective central memory CTL response against the P815 tumor
Tanja I. Naslund et al.
JOURNAL OF IMMUNOLOGY (2007)
Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survival
W. Scott Webster et al.
CANCER (2006)
An inducible mouse model of melanoma expressing a defined tumor antigen
IJ Huijbers et al.
CANCER RESEARCH (2006)
Addressing the Fas counterattack controversy:: Blocking Fas ligand expression suppresses tumor immune evasion of colon cancer in vivo
AE Ryan et al.
CANCER RESEARCH (2005)
Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance
G Willimsky et al.
NATURE (2005)
Thymocyte-intrinsic genetic factors influence CD8 T cell lineage commitment and affect selection of a tumor-reactive TCR
A Shanker et al.
JOURNAL OF IMMUNOLOGY (2004)
Functional significance of the perforin/granzyme cell death pathway
JA Trapani et al.
NATURE REVIEWS IMMUNOLOGY (2002)
TNF-Mediated toxicity after massive induction of specific CD8+ T cells following immunization of mice with a tumor-specific peptide
J Bilsborough et al.
JOURNAL OF IMMUNOLOGY (2002)
Activation-induced cell death: The controversial role of Fas and Fas ligand in immune privilege and tumour counterattack
S Maher et al.
IMMUNOLOGY AND CELL BIOLOGY (2002)
分享论文
